Harmony Gold Mining Co. (HMY) Stock Price Today
Replimune's melanoma drug gets FDA nod but faces legal probe over data practices
Replimune Group's melanoma drug Tudriqev received accelerated FDA approval after two prior rejections, based on a 24.20% response rate in trials. Following this, BMO Capital raised its price target for Replimune stock from $16 to $20, indicating stro...
Digital Realty backs Texas Governor Abbott's plan for responsible data center growth amid rising AI demand.
Digital Realty, the largest cloud- and carrier-neutral data center platform, supports Texas Governor Abbott's initiative for responsible and transparent data center investment in Texas. The company emphasizes collaboration with officials and communit...
Verisk Analytics CEO Lee Shavel sells 2,500 shares for $550,000.
Verisk Analytics CEO Lee Shavel has sold 2,500 shares of the company, generating $550,000 from the transaction. This sale may indicate personal portfolio adjustments or strategic financial planning by the CEO. Investors might watch for any further in...
Replimune's stock jumps after FDA approves its first skin cancer drug Tudriqev
Replimune Group Inc. received FDA approval for Tudriqev, its first drug targeting a difficult form of skin cancer, marking a major milestone for the biotech company. Despite earlier rejections and concerns over clinical data quality, the FDA granted ...
Man Group PLC discloses 0.57% stake in Bodycote Plc, reducing long equity swap positions.
Man Group PLC has publicly disclosed holding a 0.57% interest in Bodycote Plc as of August 6, 2026. The disclosure reveals that Man Group is reducing its long positions through multiple equity swap transactions at varying prices. This update is part ...
ADW Capital demands Driven Brands board start immediate public sale process amid valuation dispute.
ADW Capital Management, holding about 4.8% of Driven Brands, publicly urged the company's board and controlling shareholder Roark Capital to initiate an immediate public sale or strategic review of the company. ADW criticized the board for rejecting ...
Convergence Long/Short Equity ETF (CLSE) outperforms peers with balanced tech exposure and lower volatility.
The Convergence Long/Short Equity ETF (CLSE) uses a mix of quantitative and fundamental strategies to hold long and short positions across about 3,000 U.S. stocks. Its short positions focus on expensive, weaker companies with higher price-to-earnings...
Class action lawsuit filed against Replimune over undisclosed FDA study issues and misleading statements.
A class action lawsuit has been filed against Replimune Group, Inc. alleging the company failed to disclose critical issues related to its FDA Biologics License Application (BLA). The lawsuit claims Replimune did not address FDA concerns about study ...
FDA panel to review GRAIL's Galleri blood test for early multi-cancer detection on Sept 23, 2026
GRAIL announced that the FDA's advisory panel will meet on September 23, 2026, to review the Premarket Approval application for its Galleri blood test, designed to detect multiple cancers early by identifying cancer-specific methylation patterns. The...
Class action lawsuit filed against Replimune over alleged misleading FDA data disclosures
A class action lawsuit has been filed against Replimune Group, alleging the company made false or misleading statements and failed to disclose critical issues related to its Biologics License Application (BLA). The suit claims Replimune did not addre...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.